NCT06985927 Self-Concept and Autobiographical Memory in Alcohol Use Disorder
| NCT ID | NCT06985927 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CHU de Reims |
| Condition | Alcohol Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-05-28 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-05-28 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study has two objectives. First, to evaluate the effectiveness of psychotherapy sessions based on self-concept and autobiographical memory in patients suffering from alcohol use disorders (AUD). Second, investigate the relationship between drinking identity and AUD. These objectives will be investigated according to a longitudinal design. In this study, the drinking identity is evaluated on its implicit dimension and on its explicit dimension. Levels of alcohol use and dependence are assessed by the amount and frequency of drinking, the duration of abstinence, and the intensity of AUD symptoms. These assessments consist three visits: on the day of inclusion, then at three months and six months after the first visit. The psychotherapy sessions consist of four individual sessions. They are inspired by the Social Identity Mapping in Addiction Recovery (SIM-AR) by Beckwith et al. (2019), combined with autobiographical reasoning exercises. Patients with an AUD, participants in the study, are recruited from the addiction department of the Etablissement Public de Santé Mentale de la Marne. To investigate the effects of individual psychotherapy sessions, two groups of patients are constituted randomly. The first group will have four psychotherapy sessions between the first visit and the second vist. The second group will not follow psychotherapy sessions but will benefit from the usual addiction treatments. The first hypothesis is that patients who have completed the psychotherapy sessions will have lower alcohol consumption (frequency, quantities, peaks) and symptoms of AUD (cravings, drinking refusal self-efficacy and feeling of recovery) than those who have not benefited from the program. The second hypothesis is that implicit and explicit levels of drinking identity will predict alcohol consumption (frequencies, quantities, peaks) and symptoms of dependence (cravings, drinking refusal self-efficacy and feeling of recovery) for all participants.
Eligibility Criteria
Inclusion Criteria: * Patients over 24 years old, men or women * Having a diagnosis of alcohol use disorder according to DSM-5 criteria * Being a native French speaker * Patients enrolled in the national healthcare insurance program * Consenting to participate to the study Exclusion Criteria: * A diagnosis of current non-stabilized psychiatric disorders according to DSM-5 criteria * The presence of another substance use disorder, except for tobacco dependence * The presence of any intellectual disability, of pervasive developmental disorders * The presence of any neurological disorder or any other disorder affecting the central nervous system including neurological complications of alcoholism * A sensorial impairment uncorrected (visual and/or hearing)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06985927 clinical trial?
This trial is open to participants of all sexes, aged 24 Years or older, studying Alcohol Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06985927 currently recruiting?
Yes, NCT06985927 is actively recruiting participants. Contact the research team at benzeroukf@epsm-marne.fr for enrollment information.
Where is the NCT06985927 trial being conducted?
This trial is being conducted at Reims, France.
Who is sponsoring the NCT06985927 clinical trial?
NCT06985927 is sponsored by CHU de Reims. The trial plans to enroll 60 participants.